stars 1 stars 2 stars 3

Traditional pharmaceutical supply chains are not designed to meet the demands of next-generation therapies. Sendum is pioneering innovative, mission-critical supply chain management solutions for patient-specific, time-critical medicines, including cell & gene therapies (CGT), mRNA, biologics, and other advanced therapies. With Sendum’s 3-Phase Resilience Plan, innovators de-risk their path to market by bringing their end-to-end therapy supply chains into controlled operation, from starting materials through manufacturing and patient delivery, helping ensure that life-saving products reach the right patient, at the right time, and under the right conditions.

Sendum Questions

The Sendum annual revenue was $5.3 million in 2026.

Wayne Chester is the CEO of Sendum.

13 people are employed at Sendum.

Sendum is based in Burnaby, British Columbia.

The NAICS codes for Sendum are [517, 517312, 5173, 51, 51731].

The SIC codes for Sendum are [48, 481].

Top Sendum Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users